Research ExplorerPublicationsTherapie der rezidivierten und fernmetastasierten Kopf-Hals-...

Therapie der rezidivierten und fernmetastasierten Kopf-Hals-Tumoren: Highlights des ASCO-Meetings 2016

Standard

Therapie der rezidivierten und fernmetastasierten Kopf-Hals-Tumoren: Highlights des ASCO-Meetings 2016. / Bußmann, L; Busch, C-J; Knecht, R.

In: HNO, Vol. 64, No. 10, 07.09.2016, p. 723-30.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Bußmann, L, Busch, C-J & Knecht, R 2016, 'Therapie der rezidivierten und fernmetastasierten Kopf-Hals-Tumoren: Highlights des ASCO-Meetings 2016', HNO, vol. 64, no. 10, pp. 723-30. https://doi.org/10.1007/s00106-016-0235-6

APA

Bußmann, L., Busch, C-J., & Knecht, R. (2016). Therapie der rezidivierten und fernmetastasierten Kopf-Hals-Tumoren: Highlights des ASCO-Meetings 2016. HNO, 64(10), 723-30. https://doi.org/10.1007/s00106-016-0235-6

Vancouver

Bußmann L, Busch C-J, Knecht R. Therapie der rezidivierten und fernmetastasierten Kopf-Hals-Tumoren: Highlights des ASCO-Meetings 2016. HNO. 2016 Sep 7;64(10):723-30. https://doi.org/10.1007/s00106-016-0235-6

Bibtex

@article{afd03695bde24597926fc75d9c23f197,
title = "Therapie der rezidivierten und fernmetastasierten Kopf-Hals-Tumoren: Highlights des ASCO-Meetings 2016",
abstract = "This year particularly phase II studies were presented at the 2016 ASCO Annual Meeting, in which new drugs (monoclonal antibodies, small molecules) were investigated in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M-HNSCC). Notably, there was a great number of studies investigating carcinoma of the nasopharynx. The studies presented in this article summarize the different therapeutic concepts in the treatment of R/M-HNSCC and represent the variety of therapeutic approaches in the recurrent and metastatic setting.",
keywords = "English Abstract, Journal Article",
author = "L Bu{\ss}mann and C-J Busch and R Knecht",
year = "2016",
month = sep,
day = "7",
doi = "10.1007/s00106-016-0235-6",
language = "Deutsch",
volume = "64",
pages = "723--30",
journal = "HNO",
issn = "0017-6192",
publisher = "Springer",
number = "10",

}

RIS

TY - JOUR

T1 - Therapie der rezidivierten und fernmetastasierten Kopf-Hals-Tumoren: Highlights des ASCO-Meetings 2016

AU - Bußmann, L

AU - Busch, C-J

AU - Knecht, R

PY - 2016/9/7

Y1 - 2016/9/7

N2 - This year particularly phase II studies were presented at the 2016 ASCO Annual Meeting, in which new drugs (monoclonal antibodies, small molecules) were investigated in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M-HNSCC). Notably, there was a great number of studies investigating carcinoma of the nasopharynx. The studies presented in this article summarize the different therapeutic concepts in the treatment of R/M-HNSCC and represent the variety of therapeutic approaches in the recurrent and metastatic setting.

AB - This year particularly phase II studies were presented at the 2016 ASCO Annual Meeting, in which new drugs (monoclonal antibodies, small molecules) were investigated in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M-HNSCC). Notably, there was a great number of studies investigating carcinoma of the nasopharynx. The studies presented in this article summarize the different therapeutic concepts in the treatment of R/M-HNSCC and represent the variety of therapeutic approaches in the recurrent and metastatic setting.

KW - English Abstract

KW - Journal Article

U2 - 10.1007/s00106-016-0235-6

DO - 10.1007/s00106-016-0235-6

M3 - SCORING: Zeitschriftenaufsatz

C2 - 27604281

VL - 64

SP - 723

EP - 730

JO - HNO

JF - HNO

SN - 0017-6192

IS - 10

ER -